ConductScience.org, home

Trial · NCT04045522

Study on Bisphosphonates Targeting Triple-negative Breast Cancer

NCT04045522, Unknown, Shengjing Hospital

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Study on Bisphosphonates Targeting Triple-negative Breast Cancer. Trials, record NCT04045522. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04045522

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Study on Bisphosphonates Targeting Triple-negative Breast Cancer
NCT number
NCT04045522
Status
Unknown
Enrollment
120 participants, estimated
Lead sponsor
Shengjing Hospital
Conditions
Breast Cancer
Interventions
Zoledronic Acid
First posted
2019-08-05
Last updated
2021-07-20

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPathologic complete response time5 yearsPathologic complete response is defined as no residual invasive tumor cells in the breast and axillary lymph nodes
SecondaryDisease-free survival5 yearsIt refers to the time from the start of the enrollment to the recurrence of the disease or the death of the patient due to disease progression.
SecondaryOverall survival5 yearsThe length of time from either the date of diagnosis or the start of treatment for cancer, that patients diagnosed with the disease are still alive.
SecondaryIncidence of osteoporosis5 yearsOsteoporosis is considered to be present when a patient's bone density or bone mineral content is more than 2.5 standard deviations below the mean value of normal adult bone density.
SecondaryIncidence of bone-related events5 yearsIncidence of bone pain, fracture and other bone related events.
SecondaryIncidence of other distant organ metastasis-related events5 yearsIncidence of metastasis to other distant organs such as the lung, liver, bone marrow, brain and ovary.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04045522

GET https://conductscience.org/api/trials/v1/NCT04045522/registered